Overview
Udo Zur Stadt practices practicing medicine in Hamburg, Germany.
Zur Stadt is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Acute Lymphoblastic Leukemia (ALL), Non-Langerhans-Cell Histiocytosis, Reticulohistiocytoma, and Bone Marrow Transplant.
They are actively involved in clinical research, co-authoring 42 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Udo Zur Stadt
Is Udo Zur Stadt a top-rated expert for Hemophagocytic Lymphohistiocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Udo Zur Stadt is classified as an Distinguished expert for Hemophagocytic Lymphohistiocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Udo Zur Stadt participate in research or clinical trials?
Yes. Udo Zur Stadt has published 42 articles and abstracts on conditions like Hemophagocytic Lymphohistiocytosis. You can view a list of Udo Zur Stadt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Zur Stadt isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Hemophagocytic LymphohistiocytosisZur Stadt isDistinguished. Learn about Hemophagocytic Lymphohistiocytosis.
- Advanced
- Chromosome 7p DeletionZur Stadt isAdvanced. Learn about Chromosome 7p Deletion.
- HistiocytosisZur Stadt isAdvanced. Learn about Histiocytosis.
- LeukemiaZur Stadt isAdvanced. Learn about Leukemia.
- Non-Langerhans-Cell Histiocytosis
- ReticulohistiocytomaZur Stadt isAdvanced. Learn about Reticulohistiocytoma.
- Experienced
- Adult T-Cell LeukemiaZur Stadt isExperienced. Learn about Adult T-Cell Leukemia.
- AlbinismZur Stadt isExperienced. Learn about Albinism.
- Bone Marrow TransplantZur Stadt isExperienced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaZur Stadt isExperienced. Learn about Burkitt Lymphoma.
- Hermansky-Pudlak SyndromeZur Stadt isExperienced. Learn about Hermansky-Pudlak Syndrome.
- L1 SyndromeZur Stadt isExperienced. Learn about L1 Syndrome.
- Oculocutaneous AlbinismZur Stadt isExperienced. Learn about Oculocutaneous Albinism.
- Oculocutaneous Albinism Type 1Zur Stadt isExperienced. Learn about Oculocutaneous Albinism Type 1.
- Oculocutaneous Albinism Type 2Zur Stadt isExperienced. Learn about Oculocutaneous Albinism Type 2.
- Platelet Storage Pool DeficiencyZur Stadt isExperienced. Learn about Platelet Storage Pool Deficiency.
- Prolidase DeficiencyZur Stadt isExperienced. Learn about Prolidase Deficiency.